Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-16 Sale | 2024-12-17 6:06 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 577 | $0.35871 | $207 | 28,602 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:54 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 7,175 | $0.55 | $3,946 | 20,279 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:21 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 356 | $0.6899 | $246 | 14,956 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:26 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 372 | $1.2622 | $470 | 15,312 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,069 | $2.635 | $2,817 | 15,684 (Direct) | View |
| 2023-05-15 Sale | 2023-05-16 8:32 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 5,000 | $27.17 | $135,864 | 1,500 (Direct) | View |
| 2023-03-15 Sale | 2023-03-16 6:02 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,084 | $19.5 | $40,638 | 48,753 (Direct) | View |
| 2021-02-01 Sale | 2021-02-03 4:15 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 3,750 | $48.15 | $180,563 | 81,648 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-14 Exercise | 2025-06-16 7:03 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 68 | $0 | 1,989 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 4:05 pm | N/A 2035-05-15 | ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-07-22 Option Award | 2025-04-01 6:07 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,500 | $0 | 2,500 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-17 6:38 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 65 | $0 | 1,989 (Direct) | View |
| 2025-01-07 Option Award | 2025-01-10 8:00 pm | N/A 2035-01-07 | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 270,000 | $0 | 270,000 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:06 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,083 | $0 | 28,602 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:54 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 21,250 | $0 | 20,279 (Direct) | View |
| 2024-09-14 Exercise | 2024-09-17 7:21 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,084 | $0 | 14,956 (Direct) | View |
| 2024-06-27 Option Award | 2024-07-01 4:00 pm | N/A 2034-06-27 | ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:26 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,083 | $0 | 15,312 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,771 | $0 | 15,684 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:23 pm | N/A 2033-12-28 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 70,311 | $0 | 70,311 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:52 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 521 | $0 | 7,753 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:49 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 521 | $0 | 7,753 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:42 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 521 | $0 | 7,753 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 5,000 | $0 | 1,500 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-05 7:35 pm | N/A 2033-05-04 | ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-03-14 Exercise | 2023-03-16 6:02 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,084 | $0 | 48,753 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 6:02 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 41,000 | $0 | 48,753 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 7:16 pm | N/A 2032-07-01 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 72,156 | $0 | 72,156 (Direct) | View |
| 2022-05-14 Option Award | 2022-05-17 3:40 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Senior VP and CFO | 5,000 | $0 | 5,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 6:20 pm | N/A 2032-05-13 | ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director | 50,000 | $0 | 500,000 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-16 4:16 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 41,687 | $0 | 41,687 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:02 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:16 pm | N/A 2031-05-14 | ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 8:45 pm | N/A 2031-03-25 | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 4:15 pm | N/A 2027-10-02 | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 3,750 | $0 | 81,648 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 4:15 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 3,750 | $5.55 | 81,648 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:03 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 8,333 | $0 | 8,333 (Direct) | View |